Donnerstag, 24. Mai | 18:41 Uhr

PRESS RELEASE: HUGIN AD-HOC/Carl Zeiss Meditec AG:Ad hoc: Carl Zeiss Meditec continues successful growth strategy with new Chief Executive Officer

Carl Zeiss Meditec AG /  / Ad hoc: Carl Zeiss Meditec continues successful growth strategy with new Chief Executive Officer processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. 

JENA - 18 January 2010
At today's meeting the Supervisory Board of Carl Zeiss Meditec agreed to the
resignation of Dr Michael Kaschke (52) from his position on the Management Board
with effect from the end of the Annual General Meeting on 4 March 2010. The
Supervisory Board appointed the member of the Management Board Dr Ludwin Monz
(46) as the company's new Chief Executive Officer to succeed Dr Michael Kaschke.
Dr Michael Kaschke intends to return to the Supervisory Board and will stand for
election at the AGM on 4 March 2010. 

Kaschke, then Chairman of the Supervisory Board, assumed the position of Chief
Executive Officer of Carl Zeiss Meditec in July 2008 in compliance with Art.
105 of the German Stock Corporation Act. 

The Supervisory Board thanks Dr Michael Kaschke for the extraordinary commitment
with which he has made a decisive contribution to the necessary realignment of
Carl Zeiss Meditec. 

Dr Ludwin Monz has been a member of the Management Board of Carl Zeiss Meditec
AG since October 2007, where he has been responsible for the strategic business
unit Ophthalmic Systems. The other members of the Management Board of Carl Zeiss
Meditec are Dr Christian Müller and Ulrich Krauss. 

Contact: 

 Eva Sesselmann                           Patrick Kofler
 Director Corporate Communications        Director Investor Relations
 Carl Zeiss Meditec AG                    Carl Zeiss Meditec AG
 Göschwitzer Straße 51-52                 Göschwitzer Straße 51-52
 07745 Jena                               07745 Jena
 Telephone: +49 3641 220-331              Telephone: +49 3641 220-106
 Fax: +49 3641 220-112                    Fax: +49 3641 220-117
 E-mail: press@meditec.zeiss.com          E-mail: investors@meditec.zeiss.com
           

Brief profile
Carl Zeiss Meditec AG, listed in the TecDAX at the German Stock Exchange (ISIN
DE0005313704), is one of the world's leading medical technology suppliers. 

The company markets innovative technologies and application-oriented solutions
to enable physicians to improve the quality of life of their patients. For the
diagnosis and treatment of eye ailments the company offers all-in-one solutions
including implants and consumables. 

In the field of microsurgery the company supplies innovative visualisation
solutions. Promising future technologies such as intraoperative radiation
therapy round off the medical technology portfolio of Carl Zeiss Meditec. 

In financial year 2008/09 (30 September) a workforce of about 2,100 generated a
turnover of EUR 640 million. The head office of Carl Zeiss Meditec is at Jena in
Germany. In addition to further subsidiaries in Germany over 50% of the
company's employees are located in the USA, Japan, Spain and France. 

Thirty-five percent of the Carl Zeiss Meditec shares are in free float. The
remaining 65 percent are held by Carl Zeiss, one of the world's leading groups
engaged in the optical and opto-electronics industry. Carl Zeiss offers
innovative solutions for the future markets Medical & Research Solutions,
Industrial Solutions and Lifestyle Products. The headquarters of Carl Zeiss AG
are located at Oberkochen, Germany. In financial year 2008/09 (balance sheet
date 30 September) the Group generated sales of about EUR 2.1 billion. Carl Zeiss
employs almost 13,000 persons, over 8,000 of them in Germany 

For further information visit: www.meditec.zeiss.de
 

[HUG#1374528] 

 --- End of Message --- 

Carl Zeiss Meditec AG
Goeschwitzer Strasse 51-52 Jena Germany 

WKN: 531370;ISIN: DE0005313704;Index:TECH All Share,TecDAX,Prime All Share;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse; 

www.meditec.zeiss.com 

(END) Dow Jones Newswires

January 18, 2010 12:52 ET (17:52 GMT)